Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
-
-
-
-
-
-
Abbvie (ABBV) PT Lowered to $107 at Deutsche Bank
-
-
-
-
-
-
-
AbbVie Announces European Fixed Income Investor Meetings
-
-
-
-
-
-
-
Notable Analyst Rating Changes 7/22: (AMZN) (AUY) (JCP) Upgraded; (ABG) (UTC) (CHK) Downgraded
-
-
-
-
-
-
-
Abbvie (ABBV): Deutsche Bank Comfortable With 20% HCV Share Assumption (GILD)
-
-
-
-
-
-
-
Celgene (CELG), Related Stocks Decline Amid Biopharma Weakness
-
-
-
-
-
-
-
Notable Analyst Rating Changes 10/23: (FITB) (DOW) (TSCO) Upgraded; (ANGI) (BA) (BBT) Downgraded
-
-
-
-
-
-
-
Notable Analyst Rating Changes 07/02: (ABBV) (ALU) (BAC) Upgraded; (TRMB) (HOG) (EPB) Downgraded
-
47,777 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All